Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Relevium Technologies Inc V.RLV.H

Alternate Symbol(s):  RLLVF

Relevium Technologies Inc. is a Canada-based company, which operates in the health and wellness industry with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operations of brands and businesses in the health and wellness markets with a focus on e-commerce. The Company operates through two wholly owned subsidiaries, BGX E-Health LLC and Biocannabix Health Corporation Inc. BGX E-Health LLC markets dietary supplements, nutraceuticals, sports nutrition, and cosmeceuticals, primarily through its Bioganix brand portfolio online in the United States. It provides a Push & Pull System by Bioganix. Push & Pull System is a comprehensive natural anti-aging system for complete skin care that combines collagen protein supplements (PUSH) and naturally sourced aloe vera skin anti-aging cream (PULL).


TSXV:RLV.H - Post by User

Post by Betteryear2on Dec 16, 2021 1:38pm
135 Views
Post# 34237650

Secures Two PPE Contracts Totaling $16 Million

Secures Two PPE Contracts Totaling $16 Million

MONTREAL, Dec. 16, 2021 (GLOBE NEWSWIRE) -- RELEVIUM TECHNOLOGIES INC. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: 6BX”) (the “Company” or Relevium”), is pleased to announce today that in the month of December it secured two PPE contracts valued at CAD$11million and CAD$5 million respectively to supply a total a total of 180 million medical grade nitrile gloves.

The Company is also pleased to announce that on December 15, 2021, the Company delivered 127.5 million medical grade nitrile gloves, representing 100% of the first contract for a total value of CAD$11M. The Company expects to deliver on the CAD$5 million contract in the month of January 2022.

Aurelio Useche, CEO of Relevium stated: “We are extremely pleased to announce the delivery of medical examination gloves, which represents a major leap forward for the Company in this space.” Mr. Useche stated further, “The supply chain for critical medical products has been gaining stability since it was disrupted by the Covid-19 pandemic. This has allowed us to develop strategic sourcing partnerships for what we believe will be a stable and growing market for many years to come.”

Mark Billings, CFO of Relevium stated: “The delivery of $11 million of revenue for the first of the two contracts represents an all-time record in terms of revenues for the Company, which is expected to generate an average of 12% gross margin for both contracts.” Mr. Billings added: “On a yearly basis the delivery of this contract represents an approximately 265% increase in revenues as compared to the revenue for fiscal years ended June 30, 2018 ($4.152 million) and June 30, 2019 ($4.053 million).”

About Relevium Technologies

Relevium Technologies Inc., is a publicly traded company, focused on international procurement, logistics, and delivery of PPE into the North American marketplace. Utilizing trusted vendors and suppliers, and integrating a comprehensive, state-of-the-art supply chain, artificial intelligence, and blockchain technology, enables a highly secure and compliant platform for delivery of PPE equipment to governments, hospitals, foundations, and various institutions.         

Email: investors@releviumcorp.com
Website: www.releviumtechnologies.com
Like us on Facebook
Follow us on Twitter
Follow us on LinkedIn

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.






https://www.globenewswire.com/news-release/2021/12/16/2353874/0/en/Relevium-Secures-Two-PPE-Contracts-Totaling-16-Million-Contracts-Result-in-Record-Revenues-and-Earnings-for-Q2-and-for-FYE-June-30-2022.html
<< Previous
Bullboard Posts
Next >>